Hair specialist in h...
Health - Beauty - Fitness
The FDA approved the use of the drug Lenvatinib in 2015 for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. This medicine is a kinase inhibitor. One can find this medicine in 10 mg and 4 mg capsules for oral administration.
Lenvatinib cost in India is reasonable, and one can purchase this medicine from various generic medicine suppliers. The Indian Pharma has been one of the certified quality medicine suppliers delivering medicines for more than 7 years.
Comments